MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Aticaprant

CAS No. : 1174130-61-0

MCE 站：Aticaprant

产品活性：Aticaprant (CERC-501) 是一种有效地可渗透中枢神经的kappa opioid受体拮抗剂，K_i值为0.807 nM。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：Opioid Receptor

In Vitro: Aticaprant (CERC-501) binds with high affinity to the human kappa opioid receptor with a 30-fold higher affinity over the human mu opioid receptor and 190-fold higher affinity over the human delta opioid receptor. Aticaprant (CERC-501) shows no appreciable affinity for several non-opioid cell surface G-protein-coupled receptor targets, including monoaminergic, muscarinic, cholinergic, and adrenergic receptors or ion channel/transporter binding targets or the central benzodiazepine binding site.

In Vivo: Aticaprant (CERC-501) has a rapid absorption (t_max=1-2 h) and good oral bioavailability (F=25%). Oral Aticaprant (CERC-501) administration selectively and potently occupies central kappa opioid receptors (ED₅₀=0.33 mg/kg), without evidence of mu or delta receptor occupancy. LY2456302 potently blocks kappa-agonist-mediated analgesia and disruption of prepulse inhibition, without affecting mu-agonist-mediated effects at doses >30-fold higher. Aticaprant (CERC-501) produces antidepressant-like effects in the mouse forced swim test and enhances the effects of imipramine and citalopram. Aticaprant (CERC-501) reduces ethanol self-administration in alcohol-preferring rats. Aticaprant (CERC-501) alleviates the nicotine withdrawal syndrome, as evidenced by decreased expression of nicotine withdrawal induced anxiety-related behavior, somatic signs, and CPA, and increased hotplate latency in nicotine withdrawn mice following pre-treatment.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Neuronal Signaling Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Neurotransmitter Receptor Compound Library  |  DAMGO  |  Naltrindole hydrochloride  |  Sinomenine hydrochloride  |  JDTic dihydrochloride  |  Matrine  |  Loperamide hydrochloride  |  Nalfurafine hydrochloride  |  Nociceptin  |  JTC-801  |  [Leu5]-Enkephalin  |  Norbinaltorphimine dihydrochloride  |  Tyr-Gly-Gly-Phe-Met-OH  |  Endomorphin 1  |  CTAP TFA  |  Endomorphin 2 TFA  |  Noscapine  |  LY2795050  |  β-Endorphin, human  |  N-Desmethylclozapine  |  BAN ORL 24  |  Dynorphin A  |  Alvimopan dihydrate  |  Asimadoline  |  Dynorphin A (1-10) (TFA)  |  Corydaline  |  Porcine dynorphin A(1-13)  |  Dermorphin  |  Dynorphin B (1-13) (TFA)

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。